The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Self-citationMetallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
Plasmid-Determined AmpC-Type β-Lactamases
Philippon, A., Arlet, G., & Jacoby, G. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.1-11.2002 · Cited by 816
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Self-citationBratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., & Quale, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1430 · Cited by 573
Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Self-citationRodríguez-Baño, J., Navarro, M. D., Romero, L., Martínez-Martínez, L., Muniain, M. A., Perea, E. J., Pérez-Cano, R., & Pascual, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1089-1094.2004 · Cited by 456
Colodner, R., Rock, W., Chazan, B., Keller, N., Guy, N., Sakran, W., & Raz, R. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1084-2 · Cited by 364
Cosgrove, S. E., Kaye, K. S., Eliopoulous, G. M., & Carmeli, Y. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.2.185 · Cited by 299
Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii
Héritier, C., Poirel, L., Fournier, P.-E., Claverie, J.-M., Raoult, D., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4174-4179.2005 · Cited by 286
CTX-M: changing the face of ESBLs in the UK
Livermore, D. M., & Hawkey, P. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki239 · Cited by 278
Self-citationZiha-Zarifi, I., Llanes, C., Köhler, T., Pechere, J.-C., & Plesiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.287 · Cited by 276
Minimising antibiotic resistance
Livermore, D. M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70166-3 · Cited by 268
Self-citationCephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
Héritier, C., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01320.x · Cited by 266
Tigecycline: what is it, and where should it be used?
Livermore, D. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki291 · Cited by 261
Self-citationGales, A. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg416 · Cited by 242
Pagani, L., Dell'Amico, E., Migliavacca, R., D'Andrea, M. M., Giacobone, E., Amicosante, G., Romero, E., & Rossolini, G. M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4264-4269.2003 · Cited by 238
Vahaboglu, H., Oztürk, R., Aygün, G., Coşkunkan, F., Yaman, A., Kaygusuz, A., Leblebicioglu, H., Balik, I., Aydin, K., & Otkun, M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2265 · Cited by 236
Poirel, L., Menuteau, O., Agoli, N., Cattoen, C., & Nordmann, P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3542-3547.2003 · Cited by 235
IS Ecp1B -Mediated Transposition of bla CTX-M in Escherichia coli
Poirel, L., Lartigue, M.-F., Decousser, J.-W., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.447-450.2005 · Cited by 229
Henwood, C. J., Gatward, T., Warner, M., James, D., Stockdale, M. W., Spence, R. P., Towner, K. J., Livermore, D. M., & Woodford, N. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.479 · Cited by 213
Self-citationGirlich, D., Naas, T., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2043-2048.2004 · Cited by 201
Jacobs, C., Joris, B., Jamin, M., Klarsov, K., van Beeumen, J., Mengin‐Lecreulx, D., van Heijenoort, J., Park, J. T., Normark, S., & Frère, J. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02268.x · Cited by 199
Kwa, A. L. H., Loh, C., Low, J. G. H., Kurup, A., & Tam, V. H. (2005) · Clinical Infectious Diseases · doi:10.1086/432583 · Cited by 191
Coelho, J. M., Turton, J. F., Kaufmann, M. E., Glover, J., Woodford, N., Warner, M., Palepou, M.-F., Pike, R., Pitt, T. L., Patel, B. C., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00699-06 · Cited by 191
Self-citationRisk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacter spp
Kaye, K. S., Cosgrove, S., Harris, A., Eliopoulos, G. M., & Carmeli, Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2628-2630.2001 · Cited by 181
Mushtaq, S., Ge, Y., & Livermore, D. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3086-3092.2004 · Cited by 164
Self-citationHernández, J. R., Martínez-Martínez, L., Cantón, R., Coque, T. M., & Pascual, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2122-2125.2005 · Cited by 163
Extended-Spectrum β-Lactamases in Enterobacteriaceae in Buenos Aires, Argentina, Public Hospitals
Quinteros, M., Radice, M., Gardella, N., Rodriguez, M. M., Costa, N., Korbenfeld, D., Couto, E., & Gutkind, G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2864-2867.2003 · Cited by 163
Carbapenemase-producingEnterobacteriaceae, U.S. Rivers
Aubron, C., Poirel, L., Ash, R. J., & Nordmann, P. (2005) · Emerging infectious diseases · doi:10.3201/eid1102.030684 · Cited by 162
Crespo, M., Woodford, N., Sinclair, A., Kaufmann, M. E., Turton, J. F., Glover, J., Vélez, J. D., Castañeda-Ramirez, C. R., Recalde, M. P., & Livermore, D. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5094-5101.2004 · Cited by 153
Self-citationMulvey, M. R., Bryce, E., Boyd, D. A., Ofner-Agostini, M., Christianson, S., Simor, A. E., & Paton, S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1204-1214.2004 · Cited by 152
Elliott, E., Brink, A. J., van Greune, J., Els, Z., Woodford, N., Turton, J. F., Warner, M., & Livermore, D. M. (2006) · Clinical Infectious Diseases · doi:10.1086/503264 · Cited by 147
Self-citationLeflon‐Guibout, V., Jurand, C., Bonacorsi, S., Espinasse, F., Guelfi, M.-C., Duportail, F., Heym, B., Bingen, É., & Nicolas-Chanoine, M.-H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3736-3742.2004 · Cited by 125
Baraniak, A., Fiett, J., Sulikowska, A., Hryniewicz, W., & Gniadkowski, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.151-159.2002 · Cited by 121
Coelho, J., Woodford, N., Afzal-Shah, M., & Livermore, D. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.756-758.2006 · Cited by 102
Self-citationBarnaud, G., Labia, R., Raskine, L., Pors, M.-J. S.-L., Philippon, A., & Arlet, G. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10519.x · Cited by 92
The threat from the pink corner
Livermore, D. M. (2003) · Annals of Medicine · doi:10.1080/07853890310001609 · Cited by 92
Self-citationIkonomidis, A., Tokatlidou, D., Kristo, I., Sofianou, D., Tsakris, A., Mantzana, P., Pournaras, S., & Maniatis, A. N. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5344-5347.2005 · Cited by 90
Kassis, N., Decré, D., Gautier, V., Burghoffer, B., Saliba, F., Mathieu, D., Samuel, D., Castaing, D., Petit, J., Dussaix, É., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki389 · Cited by 89
Mammeri, H., Poirel, L., Bemer, P., Drugeon, H., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.716-720.2004 · Cited by 70
The increasing role of Acinetobacter species as nosocomial pathogens
Bergogne-Bérézin, E. (2007) · Current Infectious Disease Reports · doi:10.1007/s11908-007-1011-2 · Cited by 62
The increasing role of Acinetobacter species as nosocomial pathogens
Bergogne-Bérézin, E. (2001) · Current Infectious Disease Reports · doi:10.1007/bf03160479 · Cited by 50
Suárez, C. J., Lolans, K., Villegas, M. V., & Quinn, J. P. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.6.915 · Cited by 39
Livermore, D. M. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.335 · Cited by 34
Self-citationDevasia, R. A., Varma, J. K., Whichard, J. M., Gettner, S. N., Cronquist, A., Hurd, S., Segler, S. D., Smith, K., Hoefer, D., Shiferaw, B., et al. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.371 · Cited by 31
Evidence of dimerisation among class D β-lactamases: kinetics of OXA-14 β-lactamase
Danel, F., Frère, J., & Livermore, D. M. (2001) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(01)00133-9 · Cited by 29
Self-citationLivermore, D. M., & Davy, K. W. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.5.916 · Cited by 24
Self-citation
Cited by
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Self-citationCarbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Tackling antibiotic resistance: the environmental framework
Berendonk, T. U., Manaia, C. M., Merlin, C., Fatta-Kassinos, D., Cytryn, E., Walsh, F., Bürgmann, H., Sørum, H., Norström, M., Pons, M.-N., et al. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3439 · Cited by 2,338
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Metadata
- Authors
- Livermore, D. M., & Woodford, N.
- Venue
- Trends in Microbiology
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 14
- Issue
- 9
- Pages
- 413-420
- ISSN
- 0966-842X (ISSN-L)
- OpenAlex
- W2074669461
- Cited by
- 510
- References
- 50
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.